Playback speed
10 seconds
Lecture Summary - ASCO 2022 on the Addition of Carfilzomib as a Third Agent in Lenalidomide-Refractory MM: Switching From Doublet to Triplet
By
ASCO 2022 Conference Coverage
FEATURING
Claudio Cerchione
By
ASCO 2022 Conference Coverage
FEATURING
Claudio Cerchione
83 views
June 8, 2022
Login to view comments.
Click here to Login